510(k) K902208
K902208 is an FDA 510(k) premarket notification submitted by Biogenex Laboratories for the device "MODIFIED OVUGEN". The FDA issued a decision of Substantially Equivalent on July 17, 1990. The device falls under product code CEP (Radioimmunoassay, Luteinizing Hormone), a Class I device regulated under 21 CFR 862.1485. Biogenex Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 17, 1990
- Date Received
- May 16, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Luteinizing Hormone
- Device Class
- Class I
- Regulation Number
- 862.1485
- Review Panel
- CH
- Submission Type